RedHill Biopharma (RDHL) Operating Expenses (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly Operating Expenses of $4.8 million for Q2 2023, down 48.2% year-over-year from $9.2 million in Q2 2022, and down 30.46% quarter-over-quarter from $6.9 million in Q1 2023.
RedHill Biopharma (RDHL) Operating Expenses (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Operating Expenses for 12 consecutive years, with $4.8 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Operating Expenses fell 48.2% year-over-year to $4.8 million; the TTM figure through Dec 2024 stood at $4.8 million (down 75.21% YoY), while the FY2025 annual figure was $8.2 million, up 26.56% from the prior year.
- Operating Expenses declined to $4.8 million in Q2 2023 per RDHL's latest filing, from $6.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $20.6 million in Q2 2021 and bottomed at $4.8 million in Q2 2023.
- Historically, Operating Expenses has averaged $10.0 million across 5 years, with a median of $9.2 million in 2020.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 122.37% — and 2022, when it plunged 55.08%.
- RedHill Biopharma's Operating Expenses stood at $6.4 million in 2019, then soared by 112.48% to $13.6 million in 2020, then slipped by 8.43% to $12.5 million in 2021, then sank by 38.78% to $7.6 million in 2022, then sank by 37.31% to $4.8 million in 2023.
- Business Quant data shows RDHL's Operating Expenses at $4.8 million in Q2 2023, $6.9 million in Q1 2023, and $7.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | 6.88 Mn |
| Dec 31, 2022 | 7.63 Mn |
| Sep 30, 2022 | 8.12 Mn |
| Jun 30, 2022 | 9.24 Mn |
| Mar 31, 2022 | 10.88 Mn |
| Dec 31, 2021 | 12.47 Mn |
| Sep 30, 2021 | 14.25 Mn |
| Jun 30, 2021 | 20.56 Mn |
| Mar 31, 2021 | 14.58 Mn |
| Dec 31, 2020 | 13.62 Mn |
| Sep 30, 2020 | 11.65 Mn |
| Jun 30, 2020 | 9.25 Mn |
| Mar 31, 2020 | 7.35 Mn |
| Dec 31, 2019 | 6.41 Mn |
| Sep 30, 2019 | 5.72 Mn |
| Jun 30, 2019 | 9.37 Mn |
| Mar 31, 2019 | 7.40 Mn |
| Dec 31, 2018 | 7.67 Mn |
| Sep 30, 2018 | 8.30 Mn |